Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Adenosine A1 and A3 receptor agonists protect the heart against ischemia

Nov. 24, 2000

Caspase inhibition offers new strategy for cardiomyopathy therapy

Nov. 24, 2000

Novel antiarrhythmic agents under study at Mochida

Nov. 23, 2000

Novel ester of sPLA2 inhibitor has improved oral bioavailability

Nov. 23, 2000

Irbesartan to be evaluated in clinical trial for new indication: heart failure

Nov. 23, 2000

Oral bosentan effective as pulmonary hypertension therapy

Nov. 23, 2000

Initial phase I results show good safety for Antrin photoangioplasty

Nov. 23, 2000

COPERNICUS results show good efficacy for carvedilol in severe HF

Nov. 22, 2000

Phase III results reported for Natrecor in CHF

Nov. 22, 2000

Val-HeFT results reported at AHA sessions

Nov. 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...